视网膜下血肿迁移新技术:引导病灶朝向人工视网膜脱离方向
回顾性介入病例系列研究纳入18例患者,经黄斑颞侧健康下方视网膜下注射tPA制造人工视网膜脱离,使后极部脱离视网膜与视网膜下血肿相通,随后玻璃体腔填充SF6气体。黄斑区视网膜下血肿大小由术前610±489微米降至术后1个月68±134微米,所有病例血肿均自黄斑颞侧向下迁移,血肿最终位置与tPA注射点(以黄斑中心凹为中心)角度平均差19°±14°,血肿朝向人工视网膜脱离部位迁移。作者认为该技术可行,可能减少黄斑上方病灶对黄斑的累及。
要点
- 经黄斑颞侧健康下方视网膜下注射tPA制造人工视网膜脱离,使后极部脱离视网膜与血肿相通。
- 术后玻璃体腔填充SF6气体,黄斑区视网膜下血肿由术前610±489微米降至术后1个月68±134微米。
- 全部病例血肿自黄斑颞侧向下迁移,最终位置与tPA注射点角度平均差19°±14°。
核心结论
- 通过病灶外视网膜下注射tPA制造人工视网膜脱离,操控视网膜下血肿向人工视网膜脱离方向迁移是可行的。
- 该方法可能减少黄斑上方病灶对黄斑的累及。
研究设计与样本
- 回顾性介入病例系列研究,共18例患者。
- 经黄斑颞侧健康下方视网膜下注射tPA制造人工视网膜脱离,使后极部脱离视网膜与视网膜下血肿相通。
- tPA输注后玻璃体腔填充SF6气体并结束手术。
主要发现
- 黄斑区视网膜下血肿大小由术前610±489微米降至术后1个月68±134微米。
- 全部病例视网膜下血肿均自黄斑颞侧向下迁移。
- 术后tPA注射点(以黄斑中心凹为中心)与血肿最终位置之间角度平均差为19°±14°,血肿朝向人工视网膜脱离部位迁移。
临床怎么用
- 作者认为该技术可行,可能减少黄斑上方病灶对黄斑的累及。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate a new method for controlling the direction of subretinal hematoma migration during tissue plasminogen activator (tPA) treatment by selecting the tPA injection site. METHODS: Retrospective, interventional case series. An artificial retinal detachment was created by subretinal injection of tPA into the healthy lower retina of 18 patients, temporal to the fovea. The posterior pole of the detached retina was continuous with the subretinal hematoma, allowing tPA to access the lesion. After tPA infusion, the vitreous cavity was filled with SF 6 gas, and the surgery was concluded. RESULTS: Foveal subretinal hematoma size decreased from 610 ± 489 µ m preoperatively to 68 ± 134 µ m 1 month postoperatively. In all the cases, the subretinal hematoma moved downward from the temporal side of the fovea. Postoperatively, the mean difference in the angle between the tPA injection site (centered on the fovea centralis) and the hematoma's final position was 19° ± 14°, and the hematomas migrated toward the artificial retinal detachment site. CONCLUSION: It is feasible to manipulate the migration of subretinal hematoma toward an artificial retinal detachment created by subretinal tPA injection outside the lesion. This approach may minimize macular compromise in lesions superior to the macula.
引用
- Goda E, Nakano Y, Koyama Y, et al. A NOVEL TECHNIQUE FOR SUBRETINAL HEMATOMA MIGRATION: Directing the Lesion Toward Artificial Retinal Detachment. Retina. 2026. PMID: 41128470. doi:10.1097/IAE.0000000000004701
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。